Aurobindo Pharma USA Inc. recalls Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for A
Recalled April 20, 2022 · FDA recall D-0766-2022 · Aurobindo Pharma USA
Hazard
Subpotent Drug: Out of Specification results for Assay · FDA Class III
Units
433,809 vials
Sold at
Nationwide in the USA.
Description
Subpotent Drug: Out of Specification results for Assay
Product
Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.
Manufacturer(s)
Aurobindo Pharma USA Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →